Advertisement

Head and Neck Pathology

, Volume 12, Issue 1, pp 52–61 | Cite as

Nasopharyngeal Angiofibroma: A Clinical, Histopathological and Immunohistochemical Study of 42 Cases with Emphasis on Stromal Features

  • Celeste Sánchez-Romero
  • Roman Carlos
  • Juan Pablo Díaz Molina
  • Lester D. R. Thompson
  • Oslei Paes de Almeida
  • Alicia Rumayor Piña
Original Paper

Abstract

Nasopharyngeal angiofibroma is a benign but aggressive tumor of unknown etiology, typically occurring in adolescent males. It is described as a rare neoplasm; however, the prevalence seems to have geographic differences. All cases referred to our head and neck clinical and pathology service were reviewed. Most of the patients presented at an advanced stage. The clinical and radiographic features are presented and discussed. Histologically, the tumor shows a highly vascular fibrous proliferation with characteristic plump, angulated and stellate cells, categorized as fibroblasts. Immunohistochemistry was performed on 42 cases to further elucidate the nature of these cells. The stromal cells expressed vimentin and factor XIIIa, the latter expressed most commonly in the giant stellate cells. Inflammation was almost exclusively present in peripheral subepithelial areas. Mast cells were abundant, even in the absence of other inflammatory cells. Lymphatics were observed principally in peripheral regions. Proliferating cells (Ki-67 reactive) were restricted to endothelial cells.

Keywords

Nasopharyngeal angiofibroma Sinonasal tumor Vascular tumor Immunohistochemistry Imagenology Adolescent Males 

Notes

Funding

This study was not funded.

Compliance with Ethical Standards

Conflict of interest

All authors declare they have no conflicts of interest.

Ethical Approval

All reviews performed in this study with human participants were done in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. As a retrospective review, informed consent was not required.

References

  1. 1.
    Prasad ML, Franchi A, Thompson LDR. Tumours of the nasopharynx: soft tissue tumours: nasopharyngeal angiofibroma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds). World health organization classification of head and neck tumours. 4th ed. Lyon, France: IARC Press; 2017. 74–75.Google Scholar
  2. 2.
    Martins MBB, de Lima FVF, Mendonça CA, et al. Nasopharyngeal angiofibroma: our experience and literature review. Int Arch Otorhinolaryngol. 2013;17(1):14–19.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Fu Y-S, Perzin KH. Non-epithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx: a clinicopathological study. I. General features and vascular tumors. Cancer. 1974;33:1275–88.CrossRefPubMedGoogle Scholar
  4. 4.
    Pauli J, Gundelach R, Vanelli-Rees A, Rees G, Campbell C, Dubey S, et al. Juvenile nasopharyngeal angiofibroma: an immunohistochemical characterisation of the stromal cell. Pathology. 2008;40(4):396–400.CrossRefPubMedGoogle Scholar
  5. 5.
    Beham A, Fletcher CDM, Kainz J, Schmid C, Humer U. Nasopharyngeal angiofibroma: an immunohistochemical study of 32 cases. Virchows Archiv A Pathol Anat. 1993;423:281–5.CrossRefGoogle Scholar
  6. 6.
    Beham A, Beham-Schmid C, Regauer S, Auböck L, Stammberger H. Nasopharyngeal angiofibroma: true neoplasm or vascular malformation? Adv Anat Pathol. 2000;7(1):36–46.CrossRefPubMedGoogle Scholar
  7. 7.
    Beham A, Kainz J, Stammberger H, Auböck L, Beham-Schmid C. Immunohistochemical and electron microscopical characterization of stromal cells in nasopharyngeal angiofibromas. Eur Arch Otorhinolaryngol. 1997;254:196–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Renkonen S, Häyry V, Heikkilä P, Leivo I, Haglund C, Mäkitie AA, et al. Stem-cell related proteins c-kit, c-myc and bmi-1 in juvenile nasopharyngeal angiofibroma-do they have a role? Virchows Arch. 2011;458:189–95.CrossRefPubMedGoogle Scholar
  9. 9.
    Silveira SM, Custódio Domingues MA, Butugan O, Brentani MM, Rogatto SR. Tumor microenvironmental genomic alterations in juvenile nasopharyngeal angiofibroma. Head Neck. 2012;34:485–92.CrossRefPubMedGoogle Scholar
  10. 10.
    Farag MM, Ghanimah SE, Ragaie A, Saleem TH. Hormonal receptors in juvenile nasopharyngeal angiofibroma. Laryngoscope. 1987;97(2):208–11.CrossRefPubMedGoogle Scholar
  11. 11.
    Hwang HC, Mills SE, Patterson K, Gown AM. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol. 1998;11(11):1122–6.PubMedGoogle Scholar
  12. 12.
    Saylam G, Yücel OT, Sungur A, Onerci M. Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol. 2006;70(2):227–34.CrossRefPubMedGoogle Scholar
  13. 13.
    Carlos R, Thompson D. R. L, Netto AC, Santos Pimenta LGG, Correia-Silva JF, Cavaliéri Gomes C, et al. Epstein-Barr virus and human herpes virus-8 are not associated with juvenile nasopharyngeal angiofibroma. Head Neck Pathol. 2008;2:145–149.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Bakshi SS, Bhattacharjee S. Juvenile nasopharyngeal angiofibroma. J Pediatr Hematol Oncol. 2016;38(6):491–2.CrossRefPubMedGoogle Scholar
  15. 15.
    Ponti G, Losi L, Pellacani G, Rossi GB, Presutti L, Mattioli F, et al. Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA). Appl Immunohistochem Mol Morphol. 2008;16(2):173–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Finerman WB. Juvenile nasopharyngeal angiofibroma in the female. AMA Arch Otolaryngol. 1951;54(6):620–3.CrossRefPubMedGoogle Scholar
  17. 17.
    Osborn DA, Sokolovski A. Juvenile nasopharyngeal angiofibroma in a female. Report of a case. Arch Otolaryngol. 1965;82(6):629–32.CrossRefPubMedGoogle Scholar
  18. 18.
    Patrocínio JA, Patrocínio LG, Borba BH, Bonatti Bde S, Guimarães AH. Nasopharyngeal angiofibroma in an elderly woman. Am J Otolaryngol. 2005;26(3):198–200.CrossRefPubMedGoogle Scholar
  19. 19.
    Salimov A, Ozer S. A rare location of angiofibroma in the inferior turbinate in young woman. Int Arch Otorhinolaryngol. 2015;19(2):187–90.PubMedGoogle Scholar
  20. 20.
    Apostol JV, Frazell EL. Juvenile nasopharyngeal angiofibroma. A clinical study. Cancer. 1965;18:869–78.CrossRefPubMedGoogle Scholar
  21. 21.
    Labra A, Chavolla-Maga R, Lopez-Ugalde A, Alanis-Calderon J, Huerta-Delgado A. Flutamide as a preoperative treatment in juvenile angiofibroma (JA) with intracranial invasion: report of 7 cases. Otolaryngol Head Neck Surg. 2004;130(4):466–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Thakar A, Gupta G, Bhalla AS, Jain V, Sharma SC, Sharma R, et al. Adjuvant therapy with flutamide for presurgical volume reduction in juvenile nasopharyngeal angiofibroma. Head Neck. 2011;33(12):1747–53. doi: 10.1002/hed.21667.CrossRefPubMedGoogle Scholar
  23. 23.
    Kania RE, Sauvaget E, Guichard JP, Chapot R, Huy PT, Herman P. Early postoperative CT scanning for juvenile nasopharyngeal angiofibroma: detection of residual disease. AJNR Am J Neuroradiol. 2005;26(1):82–8.PubMedGoogle Scholar
  24. 24.
    Rogers DJ, Bevans SE, Harsha WJ. Endoscopic resection of juvenile nasopharyngeal angiofibroma. Adv Otorhinolaryngol. 2012;73:132–6.PubMedGoogle Scholar
  25. 25.
    Gisselsson L, Lindgren M, Stenram U. Sarcomatous transformation of a juvenile, nasopharyngeal angiofibroma. Acta Pathol Microbiol Scand. 1958;42(4):305–12.CrossRefPubMedGoogle Scholar
  26. 26.
    Donald PJ. Sarcomatous degeneration in a nasopharyngeal angiofibroma. Otolaryngol Head Neck Surg. 1979;87(1):42–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Spagnolo DV, Papadimitriou JM, Archer M. Postirradiation malignant fibrous histiocytoma arising in juvenile nasopharyngeal angiofibroma and producing alpha-1-antitrypsin. Histopathology. 1984;8(2):339–52.CrossRefPubMedGoogle Scholar
  28. 28.
    The World Bank. Data. [Internet]. Washington, DC. Available from http://data.worldbank.org/country/guatemala28. Accessed Mar 2017.
  29. 29.
    World Food Program. Guatemala. [Internet]. Rome. Available from http://www1.wfp.org/countries/guatemala. Accessed Mar 2017.
  30. 30.
    Mishra S, Praveena NM, Panigrahi RG, Gupta YM. Imaging in the diagnosis of juvenile nasopharyngeal angiofibroma. J Clin Imaging Sci. 2013;3(Suppl 1):1.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Pardhe N, Chhibber N, Agarwal D, Jain M, Vijay P. Juvenile nasopharyngeal angiofibroma extending into the oral cavity: a rare entity. J Clin Diagn Res. 2015;9(6):ZD31-3.PubMedGoogle Scholar
  32. 32.
    Zhang M, Sun X, Yu H, Hu L, Wang D. Biological distinctions between juvenile nasopharyngeal angiofibroma and vascular malformation: an immunohistochemical study. Acta Histochem. 2011;113:626–30.CrossRefPubMedGoogle Scholar
  33. 33.
    Nemeth AJ, Penneys NS. Factor XIIa is expressed by fibroblasts in fibrovascular tumors. J Cutan Pathol. 1989;16:266–71.CrossRefPubMedGoogle Scholar
  34. 34.
    Cerio R, Griffiths CEM, Cooper KD, Nickoloff BJ, Headington JT. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol. 1989;121:421–31.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  1. 1.Oral Pathology Section, Department of Oral Diagnosis, Piracicaba Dental SchoolUniversity of Campinas/UNICAMPPiracicabaBrazil
  2. 2.Centro Clínico de Cabeza y Cuello/Hospital Herrera LlerandiGuatemalaGuatemala
  3. 3.Unidad Nacional de Oncología Pediátrica (UNOP)/Centro Clínico de Cabeza y CuelloGuatemalaGuatemala
  4. 4.Southern California Permanente Medical Group, Department of PathologyWoodland Hills Medical CenterWoodland HillsUSA

Personalised recommendations